Ocular Therapeutix Balance Sheet - Annual (NASDAQ:OCUL)

Add to My Stocks
$6.43 $0 (0%) OCUL stock closing price Sep 20, 2018 (Closing)

The Ocular Therapeutix balance sheet is a snapshot of the company's financial health at a given point of time, whereas the other two financial statements are for a particular accounting period. All three financial statements should be used to measure the financial performance of the company, and should form a part of the Ocular Therapeutix stock analysis. Annual results announcements include the release of all three financial statements, of which the balance sheet is one. Ocular Therapeutix balance sheet indicates an asset turnover ratio of 0.04 and debt to equity ratio of 0.34. Also check Ocular Therapeutix revenue and Ocular Therapeutix operating cash flow for the same period.

View latest 10 year balance sheet data to check Ocular Therapeutix financial performance.
show more
View Previous Years
View Next Years
Fiscal year is Jan - Dec201720162015201420132012
Marketable Securities-35.2M74.28M37.43M--
Raw Materials------
Work In Progress------
Finished Goods------
Notes Receivable------
Other Current Assets1.45M1.39M1.59M---
Total Current Assets
Property Plant & Equipment15.81M7.13M6.03M4M2.57M2.05M
Accumulated Depreciation5.34M3.81M2.93M2.22M1.67M1.27M
Net Property Plant & Equipment
Investment & Advances------
Other Non-Current Assets------
Deferred Charges------
Deposits & Other Assets1.61M1.72M----
Total Assets
Notes Payable5.54M1.54M-1.35M1.8M1.8M
Accounts Payable3.57M2.11M1.95M1.31M--
Current Portion Long-Term Debt------
Current Portion Capital Leases------
Accrued Expenses4.31M4.63M3.37M3.01M-1.08M
Income Taxes Payable------
Other Current Liabilities------
Total Current Liabilities
Deferred Taxes/Income3.38M-----
Convertible Debt------
Long-Term Debt12.47M14.09M15.27M13.51M-2.25M
Non-Current Capital Leases------
Other Long-Term Liabilities------
Total Liabilities
Minority Interest----74.59M-
Preferred Stock-----65.82M
Common Stock Net------
Capital Surplus263.4M225.88M218.83M148.12M1.3M-
Retained Earnings-237.26M-173.87M-129.17M-89.42M-60.78M-47.46M
Treasury Stock------
Other Liabilities--0.01M-0.06M---
Shareholders Equity26.14M52M89.58M58.69M-59.47M-46.61M
Total Liabilities & Shareholders Equity55.43M74.93M110.3M78.19M19.14M25.28M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Apart from balance sheet items, an investor would do well to keep track of the Ocular Therapeutix stock price by looking at Ocular Therapeutix historical stock prices. One can compare PE with industry average by looking at the Ocular Therapeutix PE ratio chart. The common balance sheet items are:

  • Assets: OCUL total assets, which was at $55.43M for 2017 is a balance sheet item representing value of what Ocular Therapeutix owns. Assets are brought to aid a firms operations, or to increase its economic value. It must be noted that tech stocks may not have a lot of assets, as the value for these companies is often derived from future earning potential.
  • Liabilities or obligations comprise of current liabilities that include short term loans, amounts payable to suppliers, or any other outstanding payments including long term liabilities that take into account long term loans for funding large projects. The total liabilities for Ocular Therapeutix is $29.28M. Shareholders' equity comes under liabilities as it is money the company owes the holders of OCUL stock.

Ocular Therapeutix Balance Sheet - Key Ratios

Current ratio
Debt to equity ratio
Asset turnover ratio
Receivables turnover
Price to book ratio